We Are a Multi-Channel Customer Engagement Services Provider

Learn More

Consumer Goods Services

Life Sciences Services

The Experience Matters

C3i Solutions, an HCL Technologies company, is a multi-channel customer engagement services provider, specializing in global, high-touch consumer, patient, and end-user management. For the past 35 years, our unique, multi-channel approach and experience in highly regulated industries have made us the partner-of-choice for some of the world’s most trusted brands. With a strategic focus on innovation, we excel at protecting our clients’ brands, while maximizing productivity and cost efficiency.

Drug Safety & Pharmacovigilance Services

We have the Process, the People, and the Technology needed to deliver high quality, scalable, product safety solutions to meet your ever-growing needs.

Learn More

Trends in Medical Information

The report provides valuable insights into how medical information contact centers are responding to global trends driving industry change

Download Now

Direct From Consumers: New Insights into Channel Preferences

Our findings give insight into consumers’ behavior and preferences, and can guide your customer care strategies going forward.

Download Now

Technology Enhanced Patient Engagement - It's a Blockbuster

The features and functions that should be top of mind when reviewing technologies to support your patient engagement program

Download Report

Surveying the Patient Engagement Landscape

We surveyed pharma professionals to better understand the current patient engagement landscape, including shared challenges, and how they are influencing strategies.

Download Now

HCL Technologies Acquires Life Sciences and Consumer Services Provider C3i Solutions

Clinical Trials & REMS in the Time of Corona: FDA & MHRA Advice and Guidance

Bart Cobert

Apr 09, 2020

Does Rapid FDA Approval Produce Drug Safety Issues?

Bart Cobert, Mar 16, 2020

Clintrials.gov Update

Bart Cobert, Feb 11, 2020

Pharmacovigilance 2030

Bart Cobert, Dec 11, 2019

FDA Draft Guidance on PMRs

Bart Cobert, Nov 24, 2019